Gene therapy has arrived. What’s next?
8:00am - 11:00am
After decades of work, gene therapies promise a revolution in medicine. How can society figure out how to afford them? Join STAT reporters Matt Herper, Ed Silverman, Nicholas Florko, and Lev Facher, along with selected experts in the field, for this STAT Plus subscriber breakfast to discuss their perspectives on this question.
How gene therapy took on cancer: Steve Rosenberg pioneered genetically editing white blood cells to kill tumors. He’ll chart this treatment’s long path to market — and offer us a look ahead.
When business and science collide: New gene therapies have immense benefits, but they come at high one-time costs. Here, leaders from the pharmaceutical and insurance industries and the public sector will discuss how to get these breakthroughs to the patients who need them.
Contact: Becky Warner
Contact Email: email@example.com